Arch Therapeutics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ARTH Over the counter 3841 https://www.archtherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arch Therapeutics Inc

Arch Therapeutics Launches Experts in Wound Care Program - Oct 18th, 2021 11:50 am
Arch Therapeutics Provides Corporate Update - Oct 13th, 2021 8:30 pm
Arch Therapeutics to Present at the LD Micro Main Event - Oct 6th, 2021 11:50 am
Arch Therapeutics Launches Coverage and Reimbursement Pilot - Oct 4th, 2021 11:50 am
Arch Therapeutics Announces Appointment of Larry Hicks to the Board - Sep 30th, 2021 11:50 am
Arch Therapeutics Partners with Lovell Government Services to Expand Distribution Capabilities - Sep 2nd, 2021 11:00 am
Arch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of Sales - Jul 12th, 2021 11:50 am
Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 2021 - Jul 7th, 2021 11:50 am
Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021 - Jun 2nd, 2021 11:50 am
Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) - May 10th, 2021 11:50 am
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer - May 3rd, 2021 11:50 am
Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) - Apr 27th, 2021 11:50 am
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results - Apr 19th, 2021 11:50 am
Arch Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021 - Mar 2nd, 2021 12:50 pm
Arch Therapeutics Announces Closing of $6.9 Million Private Placement - Feb 18th, 2021 12:50 pm
Arch Therapeutics Announces $6.9 Million Private Placement - Feb 12th, 2021 5:45 am
Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 - 14, 2021 - Jan 5th, 2021 12:55 pm
Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc. - Jan 4th, 2021 12:50 pm
Arch Therapeutics to Present at the 13th Annual LD Micro Main Event Conference - Dec 11th, 2020 12:50 pm
Arch Raises Approximately $1.1 Million with Convertible Note Issuance - Nov 10th, 2020 12:50 pm